CoVac-1

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCoVac-1
Drug Alias NameSARS-CoC-2 HLA-DR peptides
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Immunologic Deficiency SyndromesCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital TuebingenUniversity Of Saskatchewan
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Immunologic Deficiency SyndromesCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A